What techniques can pharma companies adopt and adapt from the tech giants dominating the stage of modern-day innovation?

What drives Novartis Oncology’s Reshema Kemps-Polanco to succeed?

Five minutes with Anat Cohen-Dayag, CEO of clinical-stage drug discovery and development company Compugen.

After dizzying heights of investment during the pandemic, biotechs have observed a slump, but the future may look more promising.

AI is being implemented into drug development to free up time, money and manpower, but how can humans and computers work together?

In his first regular column for GOLD, Davidek Herron discusses digital transformation in pharma and pursuing operational excellence.

With opioid abuse showing little sign of abating, what role can pharma play in addressing the crisis?

Kenya is home to a budding pharma sector, but the country still faces access to medicine challenges. What are they, and how can pharma help?

Hear from two industry thought leaders to find out how the pharmaceutical industry is harnessing the COVID-19 to advance rather than derail their mission to improve female representation.

Clinical trials of the past struggled with patient enrolment and cost efficiency. What can the pharmaceutical industry learn to improve them?

In this roundtable, hear from two industry thought leaders who share their ideas on how to build synergy between pharma and patients.

What is it like to switch from medicine to MA, and are we about to see this spike in the wake of COVID-19?

With continued drive for equality across the pharma industry, the issue of parental leave is coming to the fore. But is the industry’s approach sufficiently transparent, and what more can be done?

How can pharma embrace post-conference momentum?

What is a digital twin and how do they benefit pharma?

How can pharma boost R&D efforts into women’s health issues?

Decentralised clinical trials are held in high regard in terms of climate impact, but are they as sustainable as they seem?

How can pharma tackle public mistrust in genomic medicine?

The pharmaceutical industry is a rich source of material for the small screen, but why is it framed as the perpetual bad boy?

How does a physician make a difference in medical affairs? Juby Jacob-Nara tells her story.

What lies in wait for pharma in the social media jungle?

Blockchain allow patients to own their data and better protects their personal information. How could it change the data landscape in pharma?

India, known by some as ‘the pharmacy of the world’, has a growing pharma reputation, but what has shaped this company’s ascension to pharmaceutical powerhouse status?

How can the industry empower MSLs as they do sales reps?